Showing 1 - 2 results of 2 for search 'Toshihiko Kitahara', query time: 0.03s
Refine Results
-
1
Combining the ABL1 kinase inhibitor ponatinib and the histone deacetylase inhibitor vorinostat: a potential treatment for BCR-ABL-positive leukemia. by Seiichi Okabe, Tetsuzo Tauchi, Shinya Kimura, Taira Maekawa, Toshihiko Kitahara, Yoko Tanaka, Kazuma Ohyashiki
Published 2014-01-01
Article -
2